Effect of acarbose versus sulfonylurea therapy on insulin sensitivity: An insulin clamp study

Current Therapeutic Research - Clinical and Experimental

Volumn 61, Issue 2, 2000, Pages 97-104

  Kinoshita, Toru ^a   Maeda, Hajime ^a   Urata, Shinichi ^a   Hirao, Koichi ^a  

^a HEC Science Clinic   (Japan)

Author keywords

Acarbose; Insulin clamp technique; Insulin sensitivity; Type 2 diabetes mellitus

Indexed keywords

ACARBOSE; HEMOGLOBIN A1C; SULFONYLUREA;

ADULT; AGED; ARTICLE; BODY MASS; CLINICAL ARTICLE; DIABETES CONTROL; DRUG EFFICACY; EXERCISE; FEMALE; GLUCOSE UTILIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INSULIN SENSITIVITY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

EID: 0034117988     PISSN: 0011393X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0011-393X(00)88531-8     Document Type: Article

References (15)

1. 1. Horii S, Fukase H, Matsuo T, et al. Synthesis and alpha-D-glucosidase inhibitory activity of N-substituted valiolamine derivatives as potential oral antidiabetic agents. J Med Chem. 1986;29:1038-1046.
2. 2. Kawamori R, Morishita T, Shiba Y, et al. The effectiveness of a new disaccharidase inhibitor AO-128 in the glycemic control of insulin-treated diabetic patients. J Jpn Diabet Soc. 1992;35:633-640.
3. 3. Chiasson JL, Josse RG, Leiter LA, et al. The effect of acarbose on insulin sensitivity in subjects with impaired glucose tolerance. Diabetes Care. 1996;19:1190-1193.
4. 4. Shinozaki K, Suzuki M, Ikebuchi M, et al. Improvement of insulin sensitivity and dyslipidemia with a new alpha-glucosidase inhibitor, voglibose, in non-diabetic hyperinsulinemic subjects. Metab Clin Exp. 1996;45:731-737.
5. 5. Reaven GM. Role of insulin resistance in human disease. Diabetes. 1988;37:1595-1607.
6. 6. DeFronzo RA, Simonson D, Ferrannini E. Hepatic and peripheral insulin resistance: A common feature of type 2 and type 1 diabetes mellitus. Diabetologia. 1982;23:313-319.
7. 7. Kaplan NM. The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglycemia, and hypertension. Arch Intern Med. 1989;49:1514-1520.
8. 8. Harano Y, Ohgaku S, Kosugi K, et al. Clinical significance of altered insulin sensitivity in diabetes mellitus assessed by glucose, insulin, and somatostatin infusion. J Clin Endocrinol Metab. 1981;52:982-987.
9. 9. Carey DG, Jenkins AB, Campbell LV, et al. Abdominal fat and insulin resistance in normal and overweight women: Direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM. Diabetes. 1996;45:633-638.
10. 10. Kemnitz JW, Roecker EB, Weindruch R, et al. Dietary restriction increases insulin sensitivity and lowers blood glucose in rhesus monkeys. Am J Physiol. 1994;266:540-547.
11. 11. Braun B, Zimmermann MB, Kretchmer N. Effects of exercise intensity on insulin sensitivity in women with non-insulin-dependent diabetes mellitus. J Appl Physiol. 1995;78: 300-306.
12. 12. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: A method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237:214-223.
13. 13. Rosseti L, Giaccari A, Defronzo RA. Glucose toxicity. Diabetes Care. 1990;13:610-630.
14. 14. Picard F, Deshaies Y. Postprandial serum lipids and tissue lipoprotein lipase are acutely altered in rats by the alpha-glucosidase inhibitor acarbose. Horm Metab Res. 1996;28: 377-380.
15. 15. Yoshino G, Furukawa S, Hirano T, et al. The minimum dose of acarbose suppresses triglyceride concentration in remnant-like particles from fasted diabetic subjects. Horm Metab Res. 1996;28:329-330.